APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oxycodone Drug

Compare research editions
View pricing & licenses

Selected research

Industry Research

Oxycodone Drug Industry Research Report 2026

29 December 2025148 pages

Choose your research edition.

Industry ResearchOxycodone Drug Industry Research Report 2026148 pages · $2,950 USDIndustry Growth & TrendsGlobal Oxycodone Drug Industry Growth and Trends Forecast to 2032128 pages · $3,450 USDMarket StructureGlobal Oxycodone Drug Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032190 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oxycodone Drug Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Oxycodone Drug Market Analysis and Forecast 2026-2032217 pages · $4,950 USD

Market perspective

The global Oxycodone Drug market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.

The North America market for Oxycodone Drug is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026–2032.

The Europe market for Oxycodone Drug is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032.

Read the full market overview

The Asia Pacific market for Oxycodone Drug is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032.

Leading global manufacturers of Oxycodone Drug include Endone, Endone, Hikma Pharmaceuticals USA, Hikma Pharmaceuticals USA, Janssen Pharmaceuticals(Johnson & Johnson), OxyContin, OxyContin, Oxynorm and Oxynorm, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report quantifies the global Oxycodone Drug market in terms of revenue (US$ million) and, where applicable, sales volume (K Units), using 2025 as the base year and providing annual historical and forecast data for 2021–2032.

It standardizes definitions of Types and Applications, harmonizes vendor attribution, and presents comparable time series by company, Type, Application, and region/country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10).

The outputs are intended to support strategy development, budgeting, and performance benchmarking for brand owners, manufacturers, retailers, channel partners, and investors; data are structured with consistent units and fields to facilitate integration into internal FP&A and BI systems.

Key Companies & Market Share Insights

This section profiles leading manufacturers, combining 2021–2025 results with a 2026–2032 outlook. It reports revenue, market share, price bands, product and application mix, regional and channel mix, and key developments (M&A, capacity additions, certifications). It also provides global revenue, average price, and—where applicable—sales volume by manufacturer, and calculates CR5/CR10 and rank changes to support comparative benchmarking.

Oxycodone Drug Market by Company

Endone

Endone

Hikma Pharmaceuticals USA

Hikma Pharmaceuticals USA

Janssen Pharmaceuticals(Johnson & Johnson)

OxyContin

OxyContin

Oxynorm

Oxynorm

Proladone

Proladone

Purdue Pharma L.P

Purdue Pharma L.P

Sanofi-Aventis S.A.

Sanofi-Aventis S.A.

Sun Pharmaceutical Industries Ltd.

Targin

Targin

Pfizer

Pfizer

Sun Pharmaceutical Industries Ltd.

Janssen Pharmaceuticals(Johnson & Johnson)

Oxycodone Drug Segment by Type

Anesthesia

Anesthesia

Others

Pain Management

Pain Management

Others

Oxycodone Drug Segment by Application

Ambulatory Surgical Centers (ASCs)

Ambulatory Surgical Centers (ASCs)

Hospitals & Clinics

Hospitals & Clinics

Oxycodone Drug Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oxycodone Drug market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oxycodone Drug and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oxycodone Drug.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;

Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc.), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 3: Detailed analysis of Oxycodone Drug manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.

Chapter 5: Production/output, value of Oxycodone Drug by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.

Chapter 6: Consumption of Oxycodone Drug in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.

Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 11: The main points and conclusions of the report.

More report detail

Tables and figures
List of Tables Table 1. Secondary Sources Table 2. Primary Sources Table 3. Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Market Value Comparison by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 5. Global Oxycodone Drug Volume and Revenue Market Size and CAGR of Manufacturers (2021 Versus 2025) Table 6. Global Oxycodone Drug Sales (K Units) of Manufacturers (2021-2026) Table 7. Global Oxycodone Drug Sales Market Share by Manufacturers (2021-2026) Table 8. Global Oxycodone Drug Revenue of Manufacturers (2021-2026) Table 9. Global Oxycodone Drug Revenue Share by Manufacturers (2021-2026) Table 10. Global Market Oxycodone Drug Average Price (US$/Unit) of Manufacturers (2021-2026) Table 11. Global Oxycodone Drug Industry Ranking, 2024 VS 2025 VS 2026 Table 12. Global Manufacturers of Oxycodone Drug, Manufacturing Sites & Headquarters Table 13. Global Manufacturers of Oxycodone Drug, Product Type & Application Table 14. Global Oxycodone Drug Manufacturers Established Date Table 15. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 16. Global Oxycodone Drug by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 17. Manufacturers Mergers & Acquisitions, Expansion Plans) Table 18. Endone Company Information Table 19. Endone Business Overview Table 20. Endone Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 21. Endone Oxycodone Drug Product Portfolio Table 22. Endone Recent Developments Table 23. Endone Company Information Table 24. Endone Business Overview Table 25. Endone Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 26. Endone Oxycodone Drug Product Portfolio Table 27. Endone Recent Developments Table 28. Hikma Pharmaceuticals USA Company Information Table 29. Hikma Pharmaceuticals USA Business Overview Table 30. Hikma Pharmaceuticals USA Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 31. Hikma Pharmaceuticals USA Oxycodone Drug Product Portfolio Table 32. Hikma Pharmaceuticals USA Recent Developments Table 33. Hikma Pharmaceuticals USA Company Information Table 34. Hikma Pharmaceuticals USA Business Overview Table 35. Hikma Pharmaceuticals USA Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 36. Hikma Pharmaceuticals USA Oxycodone Drug Product Portfolio Table 37. Hikma Pharmaceuticals USA Recent Developments Table 38. Janssen Pharmaceuticals(Johnson & Johnson) Company Information Table 39. Janssen Pharmaceuticals(Johnson & Johnson) Business Overview Table 40. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 41. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product Portfolio Table 42. Janssen Pharmaceuticals(Johnson & Johnson) Recent Developments Table 43. OxyContin Company Information Table 44. OxyContin Business Overview Table 45. OxyContin Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 46. OxyContin Oxycodone Drug Product Portfolio Table 47. OxyContin Recent Developments Table 48. OxyContin Company Information Table 49. OxyContin Business Overview Table 50. OxyContin Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 51. OxyContin Oxycodone Drug Product Portfolio Table 52. OxyContin Recent Developments Table 53. Oxynorm Company Information Table 54. Oxynorm Business Overview Table 55. Oxynorm Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 56. Oxynorm Oxycodone Drug Product Portfolio Table 57. Oxynorm Recent Developments Table 58. Oxynorm Company Information Table 59. Oxynorm Business Overview Table 60. Oxynorm Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 61. Oxynorm Oxycodone Drug Product Portfolio Table 62. Oxynorm Recent Developments Table 63. Proladone Company Information Table 64. Proladone Business Overview Table 65. Proladone Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 66. Proladone Oxycodone Drug Product Portfolio Table 67. Proladone Recent Developments Table 68. Proladone Company Information Table 69. Proladone Business Overview Table 70. Proladone Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 71. Proladone Oxycodone Drug Product Portfolio Table 72. Proladone Recent Developments Table 73. Purdue Pharma L.P Company Information Table 74. Purdue Pharma L.P Business Overview Table 75. Purdue Pharma L.P Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 76. Purdue Pharma L.P Oxycodone Drug Product Portfolio Table 77. Purdue Pharma L.P Recent Developments Table 78. Purdue Pharma L.P Company Information Table 79. Purdue Pharma L.P Business Overview Table 80. Purdue Pharma L.P Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 81. Purdue Pharma L.P Oxycodone Drug Product Portfolio Table 82. Purdue Pharma L.P Recent Developments Table 83. Sanofi-Aventis S.A. Company Information Table 84. Sanofi-Aventis S.A. Business Overview Table 85. Sanofi-Aventis S.A. Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 86. Sanofi-Aventis S.A. Oxycodone Drug Product Portfolio Table 87. Sanofi-Aventis S.A. Recent Developments Table 88. Sanofi-Aventis S.A. Company Information Table 89. Sanofi-Aventis S.A. Business Overview Table 90. Sanofi-Aventis S.A. Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 91. Sanofi-Aventis S.A. Oxycodone Drug Product Portfolio Table 92. Sanofi-Aventis S.A. Recent Developments Table 93. Sun Pharmaceutical Industries Ltd. Company Information Table 94. Sun Pharmaceutical Industries Ltd. Business Overview Table 95. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 96. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product Portfolio Table 97. Sun Pharmaceutical Industries Ltd. Recent Developments Table 98. Targin Company Information Table 99. Targin Business Overview Table 100. Targin Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 101. Targin Oxycodone Drug Product Portfolio Table 102. Targin Recent Developments Table 103. Targin Company Information Table 104. Targin Business Overview Table 105. Targin Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 106. Targin Oxycodone Drug Product Portfolio Table 107. Targin Recent Developments Table 108. Pfizer Company Information Table 109. Pfizer Business Overview Table 110. Pfizer Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 111. Pfizer Oxycodone Drug Product Portfolio Table 112. Pfizer Recent Developments Table 113. Pfizer Company Information Table 114. Pfizer Business Overview Table 115. Pfizer Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 116. Pfizer Oxycodone Drug Product Portfolio Table 117. Pfizer Recent Developments Table 118. Sun Pharmaceutical Industries Ltd. Company Information Table 119. Sun Pharmaceutical Industries Ltd. Business Overview Table 120. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 121. Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product Portfolio Table 122. Sun Pharmaceutical Industries Ltd. Recent Developments Table 123. Janssen Pharmaceuticals(Johnson & Johnson) Company Information Table 124. Janssen Pharmaceuticals(Johnson & Johnson) Business Overview Table 125. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 126. Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product Portfolio Table 127. Janssen Pharmaceuticals(Johnson & Johnson) Recent Developments Table 128. Global Oxycodone Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Table 129. Global Oxycodone Drug Sales by Region (2021-2026) & (K Units) Table 130. Global Oxycodone Drug Sales Market Share by Region (2021-2026) Table 131. Global Oxycodone Drug Sales by Region (2027-2032) & (K Units) Table 132. Global Oxycodone Drug Sales Market Share by Region (2027-2032) Table 133. Global Oxycodone Drug Revenue by Region (2021-2026) & (US$ Million) Table 134. Global Oxycodone Drug Revenue Market Share by Region (2021-2026) Table 135. Global Oxycodone Drug Revenue by Region (2027-2032) & (US$ Million) Table 136. Global Oxycodone Drug Revenue Market Share by Region (2027-2032) Table 137. North America Oxycodone Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 138. North America Oxycodone Drug Sales by Country (2021-2026) & (K Units) Table 139. North America Oxycodone Drug Sales by Country (2027-2032) & (K Units) Table 140. North America Oxycodone Drug Revenue by Country (2021-2026) & (US$ Million) Table 141. North America Oxycodone Drug Revenue by Country (2027-2032) & (US$ Million) Table 142. Europe Oxycodone Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 143. Europe Oxycodone Drug Sales by Country (2021-2026) & (K Units) Table 144. Europe Oxycodone Drug Sales by Country (2027-2032) & (K Units) Table 145. Europe Oxycodone Drug Revenue by Country (2021-2026) & (US$ Million) Table 146. Europe Oxycodone Drug Revenue by Country (2027-2032) & (US$ Million) Table 147. Asia Pacific Oxycodone Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 148. Asia Pacific Oxycodone Drug Sales by Country (2021-2026) & (K Units) Table 149. Asia Pacific Oxycodone Drug Sales by Country (2027-2032) & (K Units) Table 150. Asia Pacific Oxycodone Drug Revenue by Country (2021-2026) & (US$ Million) Table 151. Asia Pacific Oxycodone Drug Revenue by Country (2027-2032) & (US$ Million) Table 152. South America Oxycodone Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 153. South America Oxycodone Drug Sales by Country (2021-2026) & (K Units) Table 154. South America Oxycodone Drug Sales by Country (2027-2032) & (K Units) Table 155. South America Oxycodone Drug Revenue by Country (2021-2026) & (US$ Million) Table 156. South America Oxycodone Drug Revenue by Country (2027-2032) & (US$ Million) Table 157. Middle East and Africa Oxycodone Drug Revenue by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 158. Middle East and Africa Oxycodone Drug Sales by Country (2021-2026) & (K Units) Table 159. Middle East and Africa Oxycodone Drug Sales by Country (2027-2032) & (K Units) Table 160. Middle East and Africa Oxycodone Drug Revenue by Country (2021-2026) & (US$ Million) Table 161. Middle East and Africa Oxycodone Drug Revenue by Country (2027-2032) & (US$ Million) Table 162. Global Oxycodone Drug Sales by Type (2021-2026) & (K Units) Table 163. Global Oxycodone Drug Sales by Type (2027-2032) & (K Units) Table 164. Global Oxycodone Drug Sales Market Share by Type (2021-2026) Table 165. Global Oxycodone Drug Sales Market Share by Type (2027-2032) Table 166. Global Oxycodone Drug Revenue by Type (2021-2026) & (US$ Million) Table 167. Global Oxycodone Drug Revenue by Type (2027-2032) & (US$ Million) Table 168. Global Oxycodone Drug Revenue Market Share by Type (2021-2026) Table 169. Global Oxycodone Drug Revenue Market Share by Type (2027-2032) Table 170. Global Oxycodone Drug Price by Type (2021-2026) & (US$/Unit) Table 171. Global Oxycodone Drug Price by Type (2027-2032) & (US$/Unit) Table 172. Global Oxycodone Drug Sales by Application (2021-2026) & (K Units) Table 173. Global Oxycodone Drug Sales by Application (2027-2032) & (K Units) Table 174. Global Oxycodone Drug Sales Market Share by Application (2021-2026) Table 175. Global Oxycodone Drug Sales Market Share by Application (2027-2032) Table 176. Global Oxycodone Drug Revenue by Application (2021-2026) & (US$ Million) Table 177. Global Oxycodone Drug Revenue by Application (2027-2032) & (US$ Million) Table 178. Global Oxycodone Drug Revenue Market Share by Application (2021-2026) Table 179. Global Oxycodone Drug Revenue Market Share by Application (2027-2032) Table 180. Global Oxycodone Drug Price by Application (2021-2026) & (US$/Unit) Table 181. Global Oxycodone Drug Price by Application (2027-2032) & (US$/Unit) Table 182. Key Raw Materials Table 183. Raw Materials Key Suppliers Table 184. Oxycodone Drug Distributors List Table 185. Oxycodone Drug Customers List Table 186. Oxycodone Drug Industry Trends Table 187. Oxycodone Drug Industry Drivers Table 188. Oxycodone Drug Industry Restraints Table 189. Authors List of This Report List of Figures Figure 1. Research Methodology Figure 2. Research Process Figure 3. Key Executives Interviewed Figure 4. Oxycodone Drug Product Image Figure 5. Global Oxycodone Drug Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 6. Global Oxycodone Drug Market Size (2021-2032) & (US$ Million) Figure 7. Global Oxycodone Drug Sales (2021-2032) & (K Units) Figure 8. Global Oxycodone Drug Average Price (US$/Unit) & (2021-2032) Figure 9. Anesthesia Product Image Figure 10. Anesthesia Product Image Figure 11. Others Product Image Figure 12. Pain Management Product Image Figure 13. Pain Management Product Image Figure 14. Others Product Image Figure 15. Ambulatory Surgical Centers (ASCs) Product Image Figure 16. Ambulatory Surgical Centers (ASCs) Product Image Figure 17. Hospitals & Clinics Product Image Figure 18. Hospitals & Clinics Product Image Figure 19. Global Oxycodone Drug Revenue Share by Manufacturers in 2025 Figure 20. Global Manufacturers of Oxycodone Drug, Manufacturing Sites & Headquarters Figure 21. Global Top 5 and 10 Oxycodone Drug Players Market Share by Revenue in 2025 Figure 22. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Global Oxycodone Drug Market Size by Region (US$ Million): 2021 VS 2025 VS 2032 Figure 24. Global Oxycodone Drug Sales by Region in 2025 Figure 25. Global Oxycodone Drug Revenue by Region in 2025 Figure 26. North America Oxycodone Drug Market Size by Country in 2025 Figure 27. North America Oxycodone Drug Sales Market Share by Country (2021-2032) Figure 28. North America Oxycodone Drug Revenue Market Share by Country (2021-2032) Figure 29. United States Oxycodone Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 30. Canada Oxycodone Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 31. Europe Oxycodone Drug Market Size by Country in 2025 Figure 32. Europe Oxycodone Drug Sales Market Share by Country (2021-2032) Figure 33. Europe Oxycodone Drug Revenue Market Share by Country (2021-2032) Figure 34. Germany Oxycodone Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 35. France Oxycodone Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 36. U.K. Oxycodone Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 37. Italy Oxycodone Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 38. Netherlands Oxycodone Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 39. Asia Pacific Oxycodone Drug Market Size by Country in 2025 Figure 40. Asia Pacific Oxycodone Drug Sales Market Share by Country (2021-2032) Figure 41. Asia Pacific Oxycodone Drug Revenue Market Share by Country (2021-2032) Figure 42. China Oxycodone Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 43. Japan Oxycodone Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 44. South Korea Oxycodone Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 45. India Oxycodone Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 46. Australia Oxycodone Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 47. China Taiwan Oxycodone Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 48. Southeast Asia Oxycodone Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 49. Southeast Asia Oxycodone Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 50. South America Oxycodone Drug Market Size by Country in 2025 Figure 51. South America Oxycodone Drug Sales Market Share by Country (2021-2032) Figure 52. South America Oxycodone Drug Revenue Market Share by Country (2021-2032) Figure 53. Mexico Oxycodone Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 54. Brazil Oxycodone Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 55. Argentina Oxycodone Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 56. Middle East and Africa Oxycodone Drug Market Size by Country in 2025 Figure 57. Middle East and Africa Oxycodone Drug Sales Market Share by Country (2021-2032) Figure 58. Middle East and Africa Oxycodone Drug Revenue Market Share by Country (2021-2032) Figure 59. Turkey Oxycodone Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 60. Saudi Arabia Oxycodone Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 61. UAE Oxycodone Drug Revenue Growth Rate (2021-2032) & (US$ Million) Figure 62. Global Oxycodone Drug Sales Market Share by Type (2021-2032) Figure 63. Global Oxycodone Drug Revenue Market Share by Type (2021-2032) Figure 64. Global Oxycodone Drug Price (US$/Unit) by Type (2021-2032) Figure 65. Global Oxycodone Drug Sales Market Share by Application (2021-2032) Figure 66. Global Oxycodone Drug Revenue Market Share by Application (2021-2032) Figure 67. Global Oxycodone Drug Price (US$/Unit) by Application (2021-2032) Figure 68. Oxycodone Drug Value Chain Figure 69. Oxycodone Drug Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Oxycodone Drug Industry Opportunities and Challenges

Scope & coverage.

Types
  • Anesthesia
  • Anesthesia
  • Others
  • Pain Management
  • Pain Management
  • Others
Applications
  • Ambulatory Surgical Centers (ASCs)
  • Ambulatory Surgical Centers (ASCs)
  • Hospitals & Clinics
  • Hospitals & Clinics
Companies covered
  • Endone
  • Endone
  • Hikma Pharmaceuticals USA
  • Hikma Pharmaceuticals USA
  • Janssen Pharmaceuticals(Johnson & Johnson)
  • OxyContin
  • OxyContin
  • Oxynorm
  • Oxynorm
  • Proladone
  • Proladone
  • Purdue Pharma L.P
  • Purdue Pharma L.P
  • Sanofi-Aventis S.A.
  • Sanofi-Aventis S.A.
  • Sun Pharmaceutical Industries Ltd.
  • Targin
  • Targin
  • Pfizer
  • Pfizer
  • Sun Pharmaceutical Industries Ltd.
  • Janssen Pharmaceuticals(Johnson & Johnson)

Inside the report.

1 Preface
  1. 1.1 Scope of Report
  2. 1.2 Reasons for Doing This Study
  3. 1.3 Research Methodology
  4. 1.4 Research Process
  5. 1.5 Data Source
  6. 1.5.1 Secondary Sources
  7. 1.5.2 Primary Sources
2 Market Overview
  1. 2.1 Product Definition
  2. 2.2 Global Market Growth Prospects
  3. 2.2.1 Global Oxycodone Drug Market Size (2021-2032)
  4. 2.2.2 Global Oxycodone Drug Sales (2021-2032)
  5. 2.2.3 Global Oxycodone Drug Market Average Price (2021-2032)
  6. 2.3 Oxycodone Drug by Type
  7. 2.3.1 Market Value Comparison by Type (2021 VS 2025 VS 2032) & (US$ Million)
  8. 2.3.2 Anesthesia
  9. 2.3.3 Anesthesia
  10. 2.3.4 Others
  11. 2.3.5 Pain Management
  12. 2.3.6 Pain Management
  13. 2.3.7 Others
  14. 2.4 Oxycodone Drug by Application
  15. 2.4.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
  16. 2.4.2 Ambulatory Surgical Centers (ASCs)
  17. 2.4.3 Ambulatory Surgical Centers (ASCs)
  18. 2.4.4 Hospitals & Clinics
  19. 2.4.5 Hospitals & Clinics
3 Market Competitive Landscape by Manufacturers
  1. 3.1 Global Oxycodone Drug Market Competitive Situation by Manufacturers (2021 Versus 2025)
  2. 3.2 Global Oxycodone Drug Sales (K Units) of Manufacturers (2021-2026)
  3. 3.3 Global Oxycodone Drug Revenue of Manufacturers (2021-2026)
  4. 3.4 Global Oxycodone Drug Average Price by Manufacturers (2021-2026)
  5. 3.5 Global Oxycodone Drug Industry Ranking, 2024 VS 2025 VS 2026
  6. 3.6 Global Manufacturers of Oxycodone Drug, Manufacturing Sites & Headquarters
  7. 3.7 Global Manufacturers of Oxycodone Drug, Product Type & Application
  8. 3.8 Global Manufacturers of Oxycodone Drug, Established Date
  9. 3.9 Global Oxycodone Drug Market CR5 and HHI
  10. 3.10 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
  1. 4.1 Endone
  2. 4.1.1 Endone Company Information
  3. 4.1.2 Endone Business Overview
  4. 4.1.3 Endone Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  5. 4.1.4 Endone Oxycodone Drug Product Portfolio
  6. 4.1.5 Endone Recent Developments
  7. 4.2 Endone
  8. 4.2.1 Endone Company Information
  9. 4.2.2 Endone Business Overview
  10. 4.2.3 Endone Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  11. 4.2.4 Endone Oxycodone Drug Product Portfolio
  12. 4.2.5 Endone Recent Developments
  13. 4.3 Hikma Pharmaceuticals USA
  14. 4.3.1 Hikma Pharmaceuticals USA Company Information
  15. 4.3.2 Hikma Pharmaceuticals USA Business Overview
  16. 4.3.3 Hikma Pharmaceuticals USA Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  17. 4.3.4 Hikma Pharmaceuticals USA Oxycodone Drug Product Portfolio
  18. 4.3.5 Hikma Pharmaceuticals USA Recent Developments
  19. 4.4 Hikma Pharmaceuticals USA
  20. 4.4.1 Hikma Pharmaceuticals USA Company Information
  21. 4.4.2 Hikma Pharmaceuticals USA Business Overview
  22. 4.4.3 Hikma Pharmaceuticals USA Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  23. 4.4.4 Hikma Pharmaceuticals USA Oxycodone Drug Product Portfolio
  24. 4.4.5 Hikma Pharmaceuticals USA Recent Developments
  25. 4.5 Janssen Pharmaceuticals(Johnson & Johnson)
  26. 4.5.1 Janssen Pharmaceuticals(Johnson & Johnson) Company Information
  27. 4.5.2 Janssen Pharmaceuticals(Johnson & Johnson) Business Overview
  28. 4.5.3 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  29. 4.5.4 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product Portfolio
  30. 4.5.5 Janssen Pharmaceuticals(Johnson & Johnson) Recent Developments
  31. 4.6 OxyContin
  32. 4.6.1 OxyContin Company Information
  33. 4.6.2 OxyContin Business Overview
  34. 4.6.3 OxyContin Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  35. 4.6.4 OxyContin Oxycodone Drug Product Portfolio
  36. 4.6.5 OxyContin Recent Developments
  37. 4.7 OxyContin
  38. 4.7.1 OxyContin Company Information
  39. 4.7.2 OxyContin Business Overview
  40. 4.7.3 OxyContin Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  41. 4.7.4 OxyContin Oxycodone Drug Product Portfolio
  42. 4.7.5 OxyContin Recent Developments
  43. 4.8 Oxynorm
  44. 4.8.1 Oxynorm Company Information
  45. 4.8.2 Oxynorm Business Overview
  46. 4.8.3 Oxynorm Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  47. 4.8.4 Oxynorm Oxycodone Drug Product Portfolio
  48. 4.8.5 Oxynorm Recent Developments
  49. 4.9 Oxynorm
  50. 4.9.1 Oxynorm Company Information
  51. 4.9.2 Oxynorm Business Overview
  52. 4.9.3 Oxynorm Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  53. 4.9.4 Oxynorm Oxycodone Drug Product Portfolio
  54. 4.9.5 Oxynorm Recent Developments
  55. 4.10 Proladone
  56. 4.10.1 Proladone Company Information
  57. 4.10.2 Proladone Business Overview
  58. 4.10.3 Proladone Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  59. 4.10.4 Proladone Oxycodone Drug Product Portfolio
  60. 4.10.5 Proladone Recent Developments
  61. 4.11 Proladone
  62. 4.11.1 Proladone Company Information
  63. 4.11.2 Proladone Business Overview
  64. 4.11.3 Proladone Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  65. 4.11.4 Proladone Oxycodone Drug Product Portfolio
  66. 4.11.5 Proladone Recent Developments
  67. 4.12 Purdue Pharma L.P
  68. 4.12.1 Purdue Pharma L.P Company Information
  69. 4.12.2 Purdue Pharma L.P Business Overview
  70. 4.12.3 Purdue Pharma L.P Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  71. 4.12.4 Purdue Pharma L.P Oxycodone Drug Product Portfolio
  72. 4.12.5 Purdue Pharma L.P Recent Developments
  73. 4.13 Purdue Pharma L.P
  74. 4.13.1 Purdue Pharma L.P Company Information
  75. 4.13.2 Purdue Pharma L.P Business Overview
  76. 4.13.3 Purdue Pharma L.P Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  77. 4.13.4 Purdue Pharma L.P Oxycodone Drug Product Portfolio
  78. 4.13.5 Purdue Pharma L.P Recent Developments
  79. 4.14 Sanofi-Aventis S.A.
  80. 4.14.1 Sanofi-Aventis S.A. Company Information
  81. 4.14.2 Sanofi-Aventis S.A. Business Overview
  82. 4.14.3 Sanofi-Aventis S.A. Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  83. 4.14.4 Sanofi-Aventis S.A. Oxycodone Drug Product Portfolio
  84. 4.14.5 Sanofi-Aventis S.A. Recent Developments
  85. 4.15 Sanofi-Aventis S.A.
  86. 4.15.1 Sanofi-Aventis S.A. Company Information
  87. 4.15.2 Sanofi-Aventis S.A. Business Overview
  88. 4.15.3 Sanofi-Aventis S.A. Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  89. 4.15.4 Sanofi-Aventis S.A. Oxycodone Drug Product Portfolio
  90. 4.15.5 Sanofi-Aventis S.A. Recent Developments
  91. 4.16 Sun Pharmaceutical Industries Ltd.
  92. 4.16.1 Sun Pharmaceutical Industries Ltd. Company Information
  93. 4.16.2 Sun Pharmaceutical Industries Ltd. Business Overview
  94. 4.16.3 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  95. 4.16.4 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product Portfolio
  96. 4.16.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  97. 4.17 Targin
  98. 4.17.1 Targin Company Information
  99. 4.17.2 Targin Business Overview
  100. 4.17.3 Targin Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  101. 4.17.4 Targin Oxycodone Drug Product Portfolio
  102. 4.17.5 Targin Recent Developments
  103. 4.18 Targin
  104. 4.18.1 Targin Company Information
  105. 4.18.2 Targin Business Overview
  106. 4.18.3 Targin Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  107. 4.18.4 Targin Oxycodone Drug Product Portfolio
  108. 4.18.5 Targin Recent Developments
  109. 4.19 Pfizer
  110. 4.19.1 Pfizer Company Information
  111. 4.19.2 Pfizer Business Overview
  112. 4.19.3 Pfizer Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  113. 4.19.4 Pfizer Oxycodone Drug Product Portfolio
  114. 4.19.5 Pfizer Recent Developments
  115. 4.20 Pfizer
  116. 4.20.1 Pfizer Company Information
  117. 4.20.2 Pfizer Business Overview
  118. 4.20.3 Pfizer Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  119. 4.20.4 Pfizer Oxycodone Drug Product Portfolio
  120. 4.20.5 Pfizer Recent Developments
  121. 4.21 Sun Pharmaceutical Industries Ltd.
  122. 4.21.1 Sun Pharmaceutical Industries Ltd. Company Information
  123. 4.21.2 Sun Pharmaceutical Industries Ltd. Business Overview
  124. 4.21.3 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  125. 4.21.4 Sun Pharmaceutical Industries Ltd. Oxycodone Drug Product Portfolio
  126. 4.21.5 Sun Pharmaceutical Industries Ltd. Recent Developments
  127. 4.22 Janssen Pharmaceuticals(Johnson & Johnson)
  128. 4.22.1 Janssen Pharmaceuticals(Johnson & Johnson) Company Information
  129. 4.22.2 Janssen Pharmaceuticals(Johnson & Johnson) Business Overview
  130. 4.22.3 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Sales, Revenue and Gross Margin (2021-2026)
  131. 4.22.4 Janssen Pharmaceuticals(Johnson & Johnson) Oxycodone Drug Product Portfolio
  132. 4.22.5 Janssen Pharmaceuticals(Johnson & Johnson) Recent Developments
5 Global Oxycodone Drug Market Scenario by Region
  1. 5.1 Global Oxycodone Drug Market Size by Region: 2021 VS 2025 VS 2032
  2. 5.2 Global Oxycodone Drug Sales by Region: 2021-2032
  3. 5.2.1 Global Oxycodone Drug Sales by Region: 2021-2026
  4. 5.2.2 Global Oxycodone Drug Sales by Region: 2027-2032
  5. 5.3 Global Oxycodone Drug Revenue by Region: 2021-2032
  6. 5.3.1 Global Oxycodone Drug Revenue by Region: 2021-2026
  7. 5.3.2 Global Oxycodone Drug Revenue by Region: 2027-2032
  8. 5.4 North America Oxycodone Drug Market Facts & Figures by Country
  9. 5.4.1 North America Oxycodone Drug Market Size by Country: 2021 VS 2025 VS 2032
  10. 5.4.2 North America Oxycodone Drug Sales by Country (2021-2032)
  11. 5.4.3 North America Oxycodone Drug Revenue by Country (2021-2032)
  12. 5.4.4 United States
  13. 5.4.5 Canada
  14. 5.5 Europe Oxycodone Drug Market Facts & Figures by Country
  15. 5.5.1 Europe Oxycodone Drug Market Size by Country: 2021 VS 2025 VS 2032
  16. 5.5.2 Europe Oxycodone Drug Sales by Country (2021-2032)
  17. 5.5.3 Europe Oxycodone Drug Revenue by Country (2021-2032)
  18. 5.5.4 Germany
  19. 5.5.5 France
  20. 5.5.6 U.K.
  21. 5.5.7 Italy
  22. 5.5.8 Netherlands
  23. 5.6 Asia Pacific Oxycodone Drug Market Facts & Figures by Country
  24. 5.6.1 Asia Pacific Oxycodone Drug Market Size by Country: 2021 VS 2025 VS 2032
  25. 5.6.2 Asia Pacific Oxycodone Drug Sales by Country (2021-2032)
  26. 5.6.3 Asia Pacific Oxycodone Drug Revenue by Country (2021-2032)
  27. 5.6.4 China
  28. 5.6.5 Japan
  29. 5.6.6 South Korea
  30. 5.6.7 India
  31. 5.6.8 Australia
  32. 5.6.9 China Taiwan
  33. 5.6.10 Southeast Asia
  34. 5.7 South America Oxycodone Drug Market Facts & Figures by Country
  35. 5.7.1 South America Oxycodone Drug Market Size by Country: 2021 VS 2025 VS 2032
  36. 5.7.2 South America Oxycodone Drug Sales by Country (2021-2032)
  37. 5.7.3 South America Oxycodone Drug Revenue by Country (2021-2032)
  38. 5.7.4 Mexico
  39. 5.7.5 Brazil
  40. 5.7.6 Argentina
  41. 5.8 Middle East and Africa Oxycodone Drug Market Facts & Figures by Country
  42. 5.8.1 Middle East and Africa Oxycodone Drug Market Size by Country: 2021 VS 2025 VS 2032
  43. 5.8.2 Middle East and Africa Oxycodone Drug Sales by Country (2021-2032)
  44. 5.8.3 Middle East and Africa Oxycodone Drug Revenue by Country (2021-2032)
  45. 5.8.4 Turkey
  46. 5.8.5 Saudi Arabia
  47. 5.8.6 UAE
6 Segment by Type
  1. 6.1 Global Oxycodone Drug Sales by Type (2021-2032)
  2. 6.1.1 Global Oxycodone Drug Sales by Type (2021-2032) & (K Units)
  3. 6.1.2 Global Oxycodone Drug Sales Market Share by Type (2021-2032)
  4. 6.2 Global Oxycodone Drug Revenue by Type (2021-2032)
  5. 6.2.1 Global Oxycodone Drug Sales by Type (2021-2032) & (US$ Million)
  6. 6.2.2 Global Oxycodone Drug Revenue Market Share by Type (2021-2032)
  7. 6.3 Global Oxycodone Drug Price by Type (2021-2032)
7 Segment by Application
  1. 7.1 Global Oxycodone Drug Sales by Application (2021-2032)
  2. 7.1.1 Global Oxycodone Drug Sales by Application (2021-2032) & (K Units)
  3. 7.1.2 Global Oxycodone Drug Sales Market Share by Application (2021-2032)
  4. 7.2 Global Oxycodone Drug Revenue by Application (2021-2032)
  5. 7.2.1 Global Oxycodone Drug Sales by Application (2021-2032) & (US$ Million)
  6. 7.2.2 Global Oxycodone Drug Revenue Market Share by Application (2021-2032)
  7. 7.3 Global Oxycodone Drug Price by Application (2021-2032)
8 Value Chain and Sales Channels Analysis of the Market
  1. 8.1 Oxycodone Drug Value Chain Analysis
  2. 8.1.1 Oxycodone Drug Key Raw Materials
  3. 8.1.2 Raw Materials Key Suppliers
  4. 8.1.3 Oxycodone Drug Production Mode & Process
  5. 8.2 Oxycodone Drug Sales Channels Analysis
  6. 8.2.1 Direct Comparison with Distribution Share
  7. 8.2.2 Oxycodone Drug Distributors
  8. 8.2.3 Oxycodone Drug Customers
9 Global Oxycodone Drug Analyzing Market Dynamics
  1. 9.1 Oxycodone Drug Industry Trends
  2. 9.2 Oxycodone Drug Industry Drivers
  3. 9.3 Oxycodone Drug Industry Opportunities and Challenges
  4. 9.4 Oxycodone Drug Industry Restraints
10 Report Conclusion
    11 Disclaimer

      GET THE RESEARCH

      Choose your license.

      Choose who needs access.
      All options are for this report and research series.

      Compare access permissions.

      Single User License
      One named user. Individual access.
      Multi User License
      Up to 5 users in the same department.
      Enterprise License
      Organization-wide access within the agreed license.

      Access applies to the purchased edition. Later editions are separate purchases.

      License options
      $2,950USD
      Buy now

      PDF by email within 3–5 working days after payment confirmation.

      Talk to an analyst
      APO Research
      Talk to an analyst